Sullivan & Cromwell LLP Logo
  • Home
  • Lawyers
  • Practices
  • Insights
  • About
  • Careers
  • Alumni
  • Twitter icon
  • LinkedIn icon
  •  icon
  • Podcasts icon
© 2025 Sullivan & Cromwell LLP
    • Home
    • Lawyers
    • Practices
    • Insights
    • About
    • Careers
    • Alumni
    Home /  About /  Rankings And Recognitions /  Rankings And Recognitions
    Rankings And Recognitions

    S&C is Top M&A Law Firm for Global and U.S. Deals in 2022

    • Our Lawyers
    • Related Practices
    January 6, 2023

    For the second consecutive year, Sullivan & Cromwell led all law firm advisers in announced global and U.S. M&A deals. The Firm advised on announced deals totaling $516.6 billion worldwide in 2022, representing a 14 percent market share, according to Refinitiv. The firm also led all law firms in completed deals, advising on deals totaling $698.2 billion worldwide.

    S&C also ranked first in the following categories, according to Refinitiv:

    • Global – completed deals for principals ($397.8 billion)
    • United States – announced deals with any U.S. involvement ($338.2 billion)
    • United States – completed deals with any U.S. involvement ($481.2 billion)
    • Europe – completed deals with any European involvement ($308 billion)
    • United Kingdom – completed deals with any U.K. involvement ($171.4 billion)
    • France – completed deals with any French involvement ($51.7 billion)

    “We are grateful for the opportunity to work alongside our clients on these transformative deals,” said Melissa Sawyer, the Global Head of S&C’s M&A practice. “Despite a drop in dealmaking from the record levels of 2021, we continued to help our clients negotiate and execute complex deals in challenging conditions. Our multi-disciplinary teams—including lawyers in our Antitrust, Executive Compensation, Financing, Intellectual Property and Tax practices—enabled clients to address the full range of issues that can arise.”

    S&C advised:

    • Amgen in its pending $28.3 billion acquisition of Horizon Therapeutics 
    • Abiomed in its $18 billion merger with Johnson & Johnson
    • Biohaven in its $11.6 billion acquisition by Pfizer
    • Porsche SE in its €10.1 billion investment in Porsche AG
    • Cornerstone in its $5.8 billion go-private acquisition by CD&R
    • e& in its $4.4 billion acquisition of a 9.8 percent stake in Vodafone
    • DigitalBridge in its $3.2 billion sale of its Wellness Infrastructure business

    Listen to Senior M&A Partner Frank Aquila and Global Head of M&A Melissa Sawyer discuss major takeaways from M&A in 2022 and potential developments for 2023.

    Learn more about S&C’s M&A practice and subscribe to our insights.

    Read More
    Stay Updated

    Subscribe to stay current on S&C Insights.

    Our Lawyers

    Our Lawyers

    Francis J. Aquila Headshot Photo
    Francis J. Aquila
    New York
    +1-212-558-4048
    Email
    vCard
    Melissa Sawyer Headshot Photo
    Melissa Sawyer
    New York
    +1-212-558-4243
    Email
    vCard
    Read More

    Related Practices

    • Antitrust
    • Credit & Leveraged Finance
    • European Competition
    • Executive Compensation
    • Intellectual Property & Technology Transactions
    • Mergers & Acquisitions
    Sullivan & Cromwell LLP Logo
    • Twitter icon
    • LinkedIn icon
    • RSS Feed icon
    • Podcasts icon
    • Home
    • Contact Us
    • Information Policy Relating to Cookies
    • Privacy Policy
    • California Privacy Policy
    • Website Notice
    • Attorney Advertising Notice
    © 2025 Sullivan & Cromwell LLP